Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin: Implications for Clinical Trial Design

被引:0
|
作者
Montorsi, Francesco [1 ]
Moschini, Marco [1 ]
Necchi, Andrea [1 ]
Deho, Federico [1 ]
Gandaglia, Giorgio [1 ]
Briganti, Alberto [1 ]
机构
[1] IRCCS Osped San Raffaele, Div Oncol, Unit Urol, Urol Res Inst, Milan, Italy
来源
JOURNAL OF UROLOGY | 2021年 / 206卷 / 06期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1528 / 1528
页数:1
相关论文
共 50 条
  • [1] Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guerin: Implications for Clinical Trial Design REPLY
    不详
    JOURNAL OF UROLOGY, 2021, 205 (06): : 1620 - 1621
  • [2] Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guerin: Implications for Clinical Trial Design EDITORIAL COMMENTS
    Matulewicz, Richard S.
    Steinberg, Gary D.
    JOURNAL OF UROLOGY, 2021, 205 (06): : 1619 - 1620
  • [3] Oncologic outcomes of Bacillus Calmette-Guerin therapy in elderly patients with nonmuscle-invasive bladder cancer: A meta-analysis
    Kazem Aghamir, Seyed Mohammad
    Khatami, Fatemeh
    Farrokhpour, Hossein
    Reis, Leonardo Oliveira
    Pishkuhi, Mahin Ahmadi
    Mohammad, Abdolreza
    PLOS ONE, 2022, 17 (05):
  • [4] Intravesical Immunomodulatory Imiquimod Enhances Bacillus Calmette-Guerin Downregulation of Nonmuscle-invasive Bladder Cancer
    Camargo, Juliana A.
    Passos, Gabriela R.
    Ferrari, Karen L.
    Billis, Athanase
    Saad, Mario J. A.
    Reis, Leonardo O.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : E587 - E593
  • [5] Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages
    Khanna, Abhinav
    Yerram, Nitin
    Zhu, Hui
    Kim, Simon
    Abouassaly, Robert
    UROLOGY, 2019, 124 : 120 - 125
  • [6] Outcomes of Intravesical bacillus Calmette-Guerin in a Multiracial Cohort with Nonmuscle Invasive Bladder Cancer
    Barry, Emily
    Agalliu, Ilir
    Maiman, Richard
    Shreck, Evan
    Kovac, Evan
    Aboumohamed, Ahmed
    Sankin, Alexander
    UROLOGY PRACTICE, 2021, 8 (01) : 100 - 105
  • [7] The impact on survival outcomes of different Bacillus Calmette-Guerin strains of nonmuscle invasive bladder cancer patients
    Liu, K.
    Zhao, H.
    Chen, X.
    Chiu, P. K.
    Ng, C.
    Teoh, J. Y.
    EUROPEAN UROLOGY, 2023, 83 : S396 - S396
  • [8] Maintenance bacillus Calmette-Guerin in high-risk nonmuscle-invasive bladder cancer - How much is enough?
    Decobert, Marc
    LaRue, Helene
    Harel, Francois
    Meyer, Francois
    Fradet, Yves
    Lacombe, Louis
    CANCER, 2008, 113 (04) : 710 - 716
  • [9] Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer
    Hugar, Lee A.
    Gilbert, Scott M.
    Sexton, Wade J.
    Kamat, Ashish M.
    Li, Roger
    CURRENT OPINION IN UROLOGY, 2021, 31 (02) : 160 - 169
  • [10] Treatment options and results of adjuvant treatment in nonmuscle-invasive bladder cancer (NMIBC) during the Bacillus Calmette-Guerin shortage
    Fankhauser, Christian Daniel
    Teoh, Jeremy Yuen-Chun
    Mostafid, Hugh
    CURRENT OPINION IN UROLOGY, 2020, 30 (03) : 365 - 369